SXTC Stock Chart & Stats
$0.06
<$0.01(15.52%)
At close: 4:00 PM EDT
$0.06
<$0.01(15.52%)
Day’s Range― - ―
52-Week Range$0.05 - $1,046.85
Previous CloseN/A
Volume241.59M
Average Volume (3M)289.38K
Market Cap
$2.06M
Enterprise Value-$18.25M
Total Cash (Recent Filing)$28.18M
Total Debt (Recent Filing)$1.12M
Price to Earnings (P/E)―
Beta0.98
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.92
Shares Outstanding32,218,080
10 Day Avg. Volume19,389
30 Day Avg. Volume289,385
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.04
Price to Sales (P/S)1.06
P/FCF Ratio-0.28
Enterprise Value/Market Cap-8.88
Enterprise Value/Revenue-8.77
Enterprise Value/Gross Profit-18.08
Enterprise Value/Ebitda2.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China SXT Pharmaceuticals News
SXTC FAQ
What was China SXT Pharmaceuticals Inc’s price range in the past 12 months?
China SXT Pharmaceuticals Inc lowest stock price was $0.05 and its highest was $1046.85 in the past 12 months.
What is China SXT Pharmaceuticals Inc’s market cap?
China SXT Pharmaceuticals Inc’s market cap is $2.06M.
When is China SXT Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China SXT Pharmaceuticals Inc’s earnings last quarter?
China SXT Pharmaceuticals Inc released its earnings results on Mar 28, 2019. The company reported $3.29 earnings per share for the quarter, beating the consensus estimate of N/A by $3.29.
Is China SXT Pharmaceuticals Inc overvalued?
According to Wall Street analysts China SXT Pharmaceuticals Inc’s price is currently Overvalued.
Does China SXT Pharmaceuticals Inc pay dividends?
China SXT Pharmaceuticals Inc does not currently pay dividends.
What is China SXT Pharmaceuticals Inc’s EPS estimate?
China SXT Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China SXT Pharmaceuticals Inc have?
China SXT Pharmaceuticals Inc has 32,218,080 shares outstanding.
What happened to China SXT Pharmaceuticals Inc’s price movement after its last earnings report?
China SXT Pharmaceuticals Inc reported an EPS of $3.29 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of China SXT Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in SXTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Technical Analysis
China Pharma Holdings
―
Prophase Labs
―
TherapeuticsMD
―
Cumberland Pharmaceuticals
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.24% Other Institutional Investors
99.76% Public Companies and
Individual Investors